HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Down-regulation of pan-T-cell antigens, particularly CD7, in acute infectious mononucleosis.

Abstract
Multiparameter flow cytometric analysis was performed on the peripheral blood samples from 25 patients with acute infectious mononucleosis. Phenotypic results were matched with those for patients without viral symptomatology. Samples from all patients with infectious mononucleosis exhibited an activated (HLA-DR+, CD38+) CD8+ cytotoxic-suppressor T-cell population with aberrant down-regulation of CD7, and samples from 2 (8%) of 25 patients also showed down-regulation of CD5. The CD8+ cells also were slightly larger than normal T cells by forward scatter characteristics. None of the control samples showed down-regulation of either antigen. Aberrant pan-T-cell antigenic expression is a criterion in the immunophenotypic diagnosis of T-cell lymphoproliferative disorders. Acute Epstein-Barr virus infection should be considered in the differential diagnosis when down-regulation of CD7 is present, especially in conjunction with an activated CD8+ T-cell population.
AuthorsJames Weisberger, Dennis Cornfield, Wojciech Gorczyca, Zach Liu
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 120 Issue 1 Pg. 49-55 (Jul 2003) ISSN: 0002-9173 [Print] England
PMID12866372 (Publication Type: Journal Article)
Chemical References
  • Antigens, CD7
  • CD5 Antigens
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Antigens, CD7 (analysis, metabolism)
  • CD5 Antigens (analysis, metabolism)
  • CD8-Positive T-Lymphocytes (immunology, metabolism, pathology)
  • Child
  • Child, Preschool
  • Down-Regulation (immunology)
  • Female
  • Flow Cytometry
  • Humans
  • Immunophenotyping
  • Infectious Mononucleosis (immunology, metabolism, pathology)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: